ETF PRO AINovember 17, 2026
IBB iShares Biotechnology ETF
Fund tearsheet · data as of the latest session · November 17, 2026
ONE YEAR OF DAILY CLOSES
0.44%expense ratio
$11.1Bfund assets
+23.2%return, YTD
—return, 1 year
−$73Mnet flow, 1 month
+$1.2Bnet flow, 1 year
23.7%realized volatility, 1y
-9.7%worst drawdown, 1y
Top ten holdings
| 1 | GILD GILEAD SCIENCES | 8.96% |
| 2 | AMGN AMGEN | 8.48% |
| 3 | VRTX VERTEX PHARMACEUTICALS | 7.78% |
| 4 | REGN REGENERON PHARMACEUTICALS | 6.51% |
| 5 | MRNA MODERNA | 5.84% |
| 6 | ARGX ARGENX SE | 3.77% |
| 7 | NTRA NATERA | 3.00% |
| 8 | BIIB BIOGEN | 2.54% |
| 9 | ONC BeiGene | 2.42% |
| 10 | RVMD REVOLUTION MEDICINES | 2.35% |
PREPARED WITH ETF PRO AI · PRIMARY MARKET DATA · INFORMATIONAL ONLY — NOT AN OFFER, RECOMMENDATION, OR INVESTMENT ADVICE · PAST PERFORMANCE DOES NOT GUARANTEE FUTURE RESULTS